Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Vision therapy wikipedia , lookup
Contact lens wikipedia , lookup
Blast-related ocular trauma wikipedia , lookup
Visual impairment due to intracranial pressure wikipedia , lookup
Corneal transplantation wikipedia , lookup
Cataract surgery wikipedia , lookup
Eyeglass prescription wikipedia , lookup
COMMONWEALTH OF AUSTRALIA Instrument number PB 78 of 2008 Determination under subsections 85A(1) and (2) and 88(1C) of the National Health Act 1953 I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 85A(1) and (2) and 88(1C) of the National Health Act 1953. Dated 9th July 2008 DIANA MACDONELL Acting Assistant Secretary Pharmaceutical Evaluation Branch Department of Health and Ageing Determination — Prescription of pharmaceutical benefits by authorised Optometrists 1 Commencement This instrument commences on 1 August 2008. 2 Repeal Instrument number PB 10 of 2008 is repealed. 3 Definition In this instrument: Act means the National Health Act 1953. 4 Form allowable For subsection 85A(1) of the Act, the form of a pharmaceutical benefit mentioned in an item of Schedule 1 that is allowable for prescription by an authorised optometrist is the form mentioned in the description of the pharmaceutical benefit in the item. Note More than 1 form may have been determined for a pharmaceutical benefit , in which case each form is allowable for prescription: see Acts Interpretation Act 1901, para 23 (b). 5 Maximum quantity or number of units (1) For paragraph 85A (2) (a) of the Act, the maximum quantity or number of units of a pharmaceutical benefit mentioned in an item of Schedule 1 that an authorised optometrist may, in 1 prescription, direct to be supplied on any 1 occasion, either for all purposes or for a particular purpose (if any) mentioned in the item, is the quantity or number of units mentioned in the item. (2) For this section, the maximum quantity of a pharmaceutical benefit mentioned in an item in Schedule 1 is in the form mentioned in the description of the pharmaceutical benefit in the item. Note A pharmaceutical benefit may or may not have a pharmaceutical item. The description of a pharmaceutical benefit in an individual item of Schedule 1 makes it clear whether the item relates to a pharmaceutical benefit that has a pharmaceutical item or not. 6 Maximum number of repeats For paragraph 85A (2) (b) of the Act, the maximum number of occasions for which an authorised optometrist may, in 1 prescription, direct that the supply of a pharmaceutical benefit mentioned in an item of Schedule 1 be repeated, either for all purposes or for a particular purpose (if any) mentioned in the item, is the number mentioned in the item. 7 Manner of administration For paragraph 85A (2) (c) of the Act, the manner of administration of a pharmaceutical benefit mentioned in an item of Schedule 1 that an authorised optometrist may, in a prescription, direct to be used is the manner of administration mentioned in the description of the pharmaceutical benefit in the item. Instrument Number PB 78 of 2008 2 8 Pharmaceutical benefits that may be prescribed by authorised optometrists For subsection 88 (1C) of the Act, an authorised optometrist is authorised to write a prescription for the supply of a pharmaceutical benefit that is mentioned in Schedule 1. 9 Particular purpose of supply of a pharmaceutical benefit For sections 4 and 5, if there are any particular purposes for which the supply of a pharmaceutical benefit may be directed: (a) those purposes are identified by the purpose code in the item of Schedule 1 dealing with the particular pharmaceutical benefit; and (b) the purpose that the purpose code stands for is set out in the lower part of the item. Instrument Number PB 78 of 2008 3 SCHEDULE 1 MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS BY AUTHORISED OPTOMETRISTS (sections 3 to 7) Pharmaceutical Benefit Listed drug Purposes of Supply Form Manner of administration Brand For all purposes (other than a particular purpose) Maximum quantity or number Maximum repeats Aciclovir Eye ointment 30 mg per g, 4.5 g Application to the eye Zovirax 1 .. Carbomer 974 Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 Application to the eye Poly Gel 3 5 Carbomer 980 Ocular lubricating gel 2 mg per g, 10 g Application to the eye GelTears 1 5 PAA Viscotears Liquid Gel Carmellose Chloramphenicol Eye drops 2 mg per g, single dose units 0.6 mL, 30 Application to the eye Viscotears 3 5 Eye drops containing carmellose sodium 5 mg per mL, 15 mL Application to the eye Refresh Tears Plus 1 5 Eye drops containing carmellose sodium 10 mg per mL, 15 mL Application to the eye Refresh Liquigel 1 5 Eye drops containing carmellose sodium 2.5 mg per mL, single dose units 0.6 mL, 24 Application to the eye TheraTears 4 5 Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30 Application to the eye Cellufresh 3 5 Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30 Application to the eye Celluvisc 3 5 Ocular lubricating gel containing carmellose sodium 10 mg per mL, single dose units 0.6 mL, 28 Application to the eye TheraTears 3 5 Eye drops 5 mg per mL, 10 mL Application to the eye Chloromycetin 1 2 1 .. 1 5 1 .. 1 .. Chlorsig Eye ointment 10 mg per g, 4 g Application to the eye Chloromycetin Chlorsig Cromoglycic Acid Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL Application to the eye Cromolux Opticrom Fluorometholone Eye drops 1 mg per mL, 5 mL Application to the eye Flucon FML Liquifilm Flurbiprofen Eye drops containing flurbiprofen sodium 300 micrograms per mL, single dose units 0.4 mL, 5 Application to the eye Instrument Number PB 78 of 2008 4 Ocufen For particular purposes (purpose code followed by quantity or number) Maximum Maximum quantity or repeats number SCHEDULE 1 MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS BY AUTHORISED OPTOMETRISTS — continued Pharmaceutical Benefit Listed drug Purposes of Supply Form Manner of administration Brand For all purposes (other than a particular purpose) Maximum quantity or number Hydrocortisone Hypromellose Maximum repeats Eye ointment containing hydrocortisone acetate 5 mg per g, 5 g Application to the eye Hycor 1 .. Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g Application to the eye Hycor 1 .. Eye drops 3 mg per mL, 15 mL Application to the eye Genteal 1 5 In a Wink Moisturising Eye drops 5 mg per mL, 15 mL Application to the eye Methopt 1 5 Hypromellose with Carbomer 980 Ocular lubricating gel 3 mg-2 mg per g, 10 g Application to the eye Genteal gel 1 5 Hypromellose with Dextran Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL Application to the eye 1 5 Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28 Application to the eye Bion Tears 3 5 Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g Application to the eye Duratears 2 5 Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g Application to the eye 1 5 Eye drops 4 mg-3 mg per mL, 15 mL Application to the eye Systane 1 5 Eye drops 4 mg-3 mg per mL, single dose units 0.7 mL, 28 Application to the eye Systane 3 5 Eye drops 14 mg per mL, 15 mL Application to the eye Liquifilm Tears 1 5 Paraffin HPMC PAA Poly-Tears Tears Naturale Poly Visc Ircal Lacri-Lube Poly Visc Polyethylene Glycol 400 with Propylene Glycol Polyvinyl Alcohol PVA Tears Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative) Application to the eye Vistil 1 5 Eye drops 30 mg per mL, 15 mL Application to the eye Liquifilm Forte 1 5 PVA Forte Instrument Number PB 78 of 2008 5 For particular purposes (purpose code followed by quantity or number) Maximum Maximum quantity or repeats number SCHEDULE 1 MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS BY AUTHORISED OPTOMETRISTS — continued Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative) Application to the eye Vistil Forte 1 5 Sulfacetamide Eye drops containing sulfacetamide sodium 100 mg per mL, 15 mL Application to the eye Bleph 10 1 2 Tamarindus indica seed polysaccharide Eye drops 10 mg per mL, 0.5 mL, 20 Application to the eye Visine Professional 3 5 Instrument Number PB 78 of 2008 6